Company news

CollPlant Biotechnologies Ltd. news in 2026

CollPlant Biotechnologies Ltd.'s news releases, calls and decks from 2026, newest first.

View company

CollPlant announces a $3.7 million private placement

October 9, 2026

LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations

October 6, 2026

CollPlant reports 2026 second quarter financial results and provides corporate update

September 30, 2026

LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads

September 24, 2026

CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement

September 22, 2026

CollPlant to Host LightSolver Investor Webinar on September 17, 2026

September 10, 2026

CollPlant appoints Dr. Ruti Ben Shlomi to its board of directors following closing of LightSolver acquisition

September 7, 2026

CollPlant completes acquisition of LightSolver, entering the photonic computing sector

September 3, 2026

CollPlant announces reverse share split

September 1, 2026

CollPlant is acquiring LightSolver- enters supercomputing and photonic computing markets

August 31, 2026

CollPlant Biotechnologies announces $2.6 million private placement

June 30, 2026

CollPlant Biotechnologies reports 2026 first quarter financial results and provides corporate update

May 29, 2026

CollPlant Biotechnologies reports 2025 financial results and provides corporate update

March 25, 2026

CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

March 23, 2026

CollPlant Biotechnologies Launches Redesigned Corporate Website

March 17, 2026

CollPlant Biotechnologies announces date for full year 2025 financial results

March 10, 2026

CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler

February 25, 2026

CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex

February 22, 2026

CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments

February 17, 2026

CollPlant Biotechnologies announces $2.0 million registered direct offering

February 5, 2026

Decks in 2026